TP53 and prostate cancer: In addition, we immunoprecipitated endogenous JMJD2A from human DU145 prostate cancer cells and then probed with the p53-K372me1 Ab (Figure 1D), revealing that endogenous JMJD2A was also methylated in DU145 cells.